Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019416
Filing Date
2018-08-06
Accepted
2018-08-06 16:02:49
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q derm-10q_20180630.htm 10-Q 1972583
2 EX-31.1 derm-ex311_8.htm EX-31.1 16929
3 EX-31.2 derm-ex312_7.htm EX-31.2 17554
4 EX-32.1 derm-ex321_6.htm EX-32.1 5767
5 EX-32.2 derm-ex322_9.htm EX-32.2 6395
  Complete submission text file 0001564590-18-019416.txt   5865372

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT derm-20180630.xml EX-101.INS 1160219
7 XBRL TAXONOMY EXTENSION SCHEMA derm-20180630.xsd EX-101.SCH 41662
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE derm-20180630_cal.xml EX-101.CAL 44733
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE derm-20180630_def.xml EX-101.DEF 146457
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE derm-20180630_lab.xml EX-101.LAB 308883
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE derm-20180630_pre.xml EX-101.PRE 248308
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

EIN.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36668 | Film No.: 18994721
SIC: 2834 Pharmaceutical Preparations